As previously mentioned, T2DM is characterized by a myriad of pathophysiological processes, including decreased insulin sensitivity, neurotransmitter receptor dysfunction, decreased pancreatic insulin and increased glucagon secretion, increased gluconeogenesis, increased lipolysis, increased renal glucose reabsorption and a reduction in incretin effects [54,101]. This evidence concerns the gene GCG and type 2 diabetes mellitus.